Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Blue Jet Healthcare Ltd (BLUEJET) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Contrast Media IntermediatesKey starting and advanced intermediates for X-ray and CT scan contrast agents; complex chemistry products with regulatory approvals.Long-term relationships, specialized chemistry expertise, regulatory compliance, and high entry barriers for competitors.B2B; leading global pharmaceutical and diagnostic companies.Advanced intermediates and bespoke molecules under contract manufacturing.403939Revenue from long-term supply contracts with multinational contrast media manufacturers.Contractual and negotiated supply agreements with fixed and variable pricing components.Rising diagnostics demand globally, aging population, chronic disease prevalence, technological advancements in imaging.
High Intensity SweetenersSaccharin and salts, used in food, beverages, oral care, pharmaceuticals, and animal feed sectors globally.Established product quality, regulatory certifications, broad customer base, and process expertise.B2B with multinational FMCG, agrochemical companies, and pharmaceutical product makers.Specialized sweetener formulations.133513Sales revenue through global distribution to FMCG and related industries.Direct sales; volume-based contracts.Health-conscious consumer trends, demand for sugar alternatives, innovation in sweetener applications.
Pharma Intermediates and APIsPharmaceutical intermediates and APIs for chronic diseases including cardiovascular, CNS, and oncology therapies targeting innovator and generic makers.Strong R&D capabilities, confidentiality, long-term partnerships, and regulatory compliance.B2B serving innovator pharmaceutical companies and generic manufacturers globally.Advanced intermediates, technology transfer projects.295529Contract manufacturing, development services, and supply agreements.Project-based contracts and supply agreements with milestones and volumes.Increasing outsourcing by pharma companies, import substitution, growth in generics and novel therapies.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions